<qa>  What is the dose preceding that at least 2 of 6 patients experience dose-limiting toxicityCohorts of 3-6 patients receive escalating doses of PV701 IV and IP until the optimal desensitization dose ODD is determined. The ODD is defined as the dose preceding that at which at least 2 of 6 patients experience dose-limiting toxicity DLT. 